D-0435-2017 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-0435-2017 was initiated by Sandoz Inc on Dec 13, 2016 and is designated Class III. Reason for recall: Subpotent Drug: out of specification results for assay test. The recall status is terminated (terminated Sep 14, 2017). Affected quantity: a) 10,200 bottles; b) 300 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 25, 2017
Initiation Date
Dec 13, 2016
Termination Date
Sep 14, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 10,200 bottles; b) 300 bottles

Product description

Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540.

Reason for recall

Subpotent Drug: out of specification results for assay test.

Distribution pattern

Nationwide in the USA

Code information

Lot #: a) FJ6599, Exp 05/17 and b) FJ6600, Exp 05/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0435-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0435-2017. Report a data issue: hello@regdatalab.com.